natasha persaud

1 week ago | renalandurologynews.com | natasha persaud

Children infected with SARS-CoV-2 who develop COVID-19 are more likely to experience new onset chronic kidney disease (CKD) and progressive CKD compared with uninfected children, according to findings from a large study. Among 1,900,146 pediatric patients younger than 21 years from 19 medical facilities in the 2020-2023 US National Institutes of Health Researching COVID to Enhance Recovery (RECOVER) initiative, 487,378 children (25.6%) experienced COVID-19.

1 week ago | hematologyadvisor.com | natasha persaud

A recent meta-analysis identifies a wide range of underappreciated risk factors for anemia following kidney transplantation. It highlights the importance of kidney disease etiology and use of erythropoiesis-stimulating agents (ESAs). Suwasin Udomkarnjananun, MD, PhD, of Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society in Bangkok, Thailand, and colleagues performed a systematic review and meta-analysis of 85 studies including data from 38,233 patients.

2 weeks ago | thecardiologyadvisor.com | natasha persaud

Patients with type 2 diabetes may have the lowest risk of progressing to moderate chronic kidney disease (CKD) and kidney failure when they use a sodium-glucose cotransporter 2 inhibitor (SGLT2i) or glucagon-like peptide-1 receptor agonist (GLP-1RA) rather than other glucose-lowering agents, investigators report.

2 weeks ago | cancertherapyadvisor.com | natasha persaud

Patients who develop secondary rectal cancer after receiving radiotherapy for prostate cancer have worse survival outcomes than patients with primary rectal cancer, and several factors may be driving this difference, according to research published in JAMA Network Open. In a case-control study, investigators compared 64 men with secondary rectal cancer (after completing radiotherapy for prostate cancer) and 604 men with primary rectal cancer treated from 1994 to 2022.

2 weeks ago | clinicaladvisor.com | natasha persaud

Secondary rectal cancer after prostate cancer radiation therapy appears to have distinct clinical genomic characteristics and worse survival odds than primary rectal cancer, investigators report. In a case-control study, investigators compared outcomes from 64 men with secondary rectal cancer and 604 male patients with primary rectal cancer treated from 1994 to 2022.